Given its central role in coordinating key oncogenic pathways and Epithelial–Mesenchymal Transition (EMT), a deeper understanding of SMARCD3’s function in gastric cancer signaling is therefore critical for identifying novel therapeutic targets [7,11,16]. The gene discussed is SMARCD3; the disease is gastric cancer.